Hold-rated reports

904 tickers rated Hold
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Guidewire Software, Inc.
GWRE·Technology
B ★★★Hold
Current$140.92
Target$150.94
Return+7.1%
Sep 14, 2026

Guidewire is a mission-critical P&C cloud platform with high switching costs, expanding margins and emerging insurance AI upside, but its premium valuation needs mid-teens revenue and high-teens ARR growth to persist after the FY2026 slowdown.

Score
71
Copart, Inc.
CPRT·Industrials
B ★★★Hold
Current$29.95
Target$37.95
Return+26.7%
Sep 13, 2026

Copart combines a high-ROIC global vehicle-auction moat and aggressive share repurchases with a historically compressed valuation, but stalled U.S. growth, margin pressure, and the $1.9B ACV integration create a meaningful execution hurdle.

Score
71
Elastic N.V.
ESTC·Technology
B ★★★Hold
Current$74.79
Target$95.52
Return+27.7%
Nov 22, 2026

Elastic combines durable enterprise search subscriptions, AI-related demand, and improving cash generation, but intense platform competition and substantial stock-based compensation could limit long-term per-share returns.

Score
70
Construction Partners, Inc.
ROAD·Industrials
B ★★★Hold
Current$69.29
Target$78.50
Return+13.3%
Nov 22, 2026

Construction Partners offers long-term Sunbelt infrastructure growth through regional consolidation and vertically integrated paving operations, but elevated leverage and acquisition-related margin pressure constrain near-term returns.

Score
70
Woodward, Inc.
WWD·Industrials
B ★★★Hold
Current$326.56
Target$323.95
Return-0.8%
Nov 21, 2026

Woodward benefits from durable aerospace aftermarket demand, high switching costs, and improving capital returns, but premium valuation and elevated manufacturing investment limit near-term upside and margin of safety.

Score
70
Hafnia Limited
HAFN·Industrials
B ★★★Hold
Current$8.82
Target$9.37
Return+6.2%
Nov 21, 2026

Hafnia offers strong tanker cash flows, disciplined leverage, and substantial shareholder distributions, but cyclical freight earnings, recent dilution, and uncertainty around its TORM investment constrain upside.

Score
70
Legend Biotech Corporation
LEGN·Healthcare
B ★★★Hold
Current$18.54
Target$34.18
Return+84.4%
Nov 13, 2026

Legend Biotech combines a clinically differentiated, growing CAR-T franchise with improving profitability and attractive sales-based valuation, but slowing U.S. adoption, single-product dependence, and negative cash flow constrain conviction.

Score
70
Resideo Technologies, Inc.
REZI·Industrials
B ★★★Hold
Current$21.46
Target$23.40
Return+9.0%
Nov 13, 2026

Resideo's focused residential controls and safety franchise offers improving margins and post-spin recovery potential, but elevated leverage, weak cash conversion, and cyclical housing demand limit near-term upside.

Score
70
Casella Waste Systems, Inc.
CWST·Industrials
B ★★★Hold
Current$98.53
Target$123.98
Return+25.8%
Nov 12, 2026

Casella Waste Systems combines recurring waste demand, valuable disposal infrastructure, and acquisition-led growth, but weak GAAP profitability, rising capital requirements, and demanding cash-flow expectations constrain near-term investment upside.

Score
70